The International Working Group on Morphology of MDS (IWGM-MDS)

Size: px
Start display at page:

Download "The International Working Group on Morphology of MDS (IWGM-MDS)"

Transcription

1 The International Working Group on Morphology of MDS (IWGM-MDS) Barbara J. Bain, St Mary s Hospital Imperial College, London, UK John M. Bennett, University of Rochester, NY, USA Richard Brunning, University of Minnesota, USA Jean E. Goasguen, University of Rennes, France Masao Tomonaga, University of Nagasaki, Japan Maria-Teresa Vallespi, Vall d Hebron Hospital, Barcelona, Spain Gina Zini, Haematology Institute, Catholic University of Sacred Heart, Rome, Italy Statistician: Alain Renault, University of Rennes and INSERM-CIC P 0203, France

2 WHO 2 RCUD R cytopenia with unilineage dysplasia * (Anemia, neutropenia, thrombopenia) Uni or bicytopenia BM: < 5% blasts RARS R cytopenia with Ring sideroblasts BM: >15% ring BM: <5% blasts RCMD R cytopenia with mulgple dysplasia Dysplasia in more >10% of the cells in 2 or 3 lineages RAEB- I RA with excess of blasts** Blood: <5% blasts BM: 5 to 9% blasts RAEB- II RA with excess of blasts Blood: 5 to 19% blasts BM: 10 to 19% blasts MDS- U unclassified Blood: cytopenias <1% blasts BM: Dysplasia in <10 cells of one or more lineage. CytogeneGc. <5% blasts MDS 5q- Anemia, Platelet, MGK 5q- * bi- cytopenia may be observed ** if 2-4% blasts in blood and <5% in BM: RAEB- I

3 nemia eutropenia hrombopenia

4 Quels sont les difficultés ou les pièges? L idengficagon des blastes L idengficagon des dysplasies QualitaGvement: DysE DysG DysM QuanGtaGvement: 10%??? Les «Ring» sidéroblastes: QualitaGvement QuanGtaGvement Les monocytes promonocytes

5 Sidéroblastes Type I = 1 à 5 grains Type II = 5 à 15 grains Type III= >15 grains en couronne >15% ring = ARS MDS/J.E.Goasguen 5

6 New proposal for Ring sideroblasts: Haematologica Nov;93(11): Definitions in the litterature: - Iron granules in perinuclear distribution, entire nucleus - Iron granules in perinuclear distribution, 1/3 nucleus - >5 granules - >10 granules New proposal: At least 5 granules in perinuclear distribution, surrounding the entire nucleus, or portion or 1/3. 3 types of sideroblasts: <5 granules >= 5 granules not perinuclear >= 5 granules perinuclear

7 Perinuclear Siderotic Granules New proposal: At least 5 granules in perinuclear distribution, surrounding the entire nucleus, or portion or 1/3.

8 Figure 4: Composite of iron stained erythroid precursors Absence of iron granules Single iron granules (type 1) Classical Ring sideroblast (type 3) Focal iron granules (type 2) Qualifies as Ring > 10 granules Scattered iron granules (type 3) (qualifies as ring - >10 granules)

9 Subtype Example Description Remarks Agranular blast Granular blast Promyelocyte Agranular blast with basophilic cytoplasm fine chromatin and nuleoli A subtype but with azurophilic granulations and absence of Golgi zone Azurophilic granulations and A clear visible Golgi zone characteristic in promyelocytes Type I blast in the FAB classification Includes Type II blast in FAB classification and Type III blast as defined by Goasguen et al Haematologica Nov;93(11): Myelodysplastic promyelocyte Promyelocyte with an irregular distribution of granulations and reduced number of granules Jean Goasguen These cells are often seen in MDS and need to be distinguished from granular blasts

10 A A G G G G G PMC PMC AbnPMC AbnPMC AbnPMC AbnPMC Jean Goasguen

11 N1 Golgi zone 1. Agranular Blast 2. Granular Blast 3. Promyelocyte 4. Abnormal Promyelocyte Jean Goasguen

12 P4 1. Agranular Blast 2. Granular Blast 3. Promyelocyte 4. Abnormal Promyelocyte Jean Goasguen

13 P16 1. Agranular Blast 2. Granular Blast 3. Promyelocyte 4. Abnormal Promyelocyte Jean Goasguen

14 Haematologica Jul;94(7):994-7.

15

16

17

18

19

20 Dysplasie de la lignée granuleuse Qualité du fro1s, qualité de la colora7on 1. QuanGté de grains dans le cytoplasme: 2. Présence de grains anormaux 3. ChromaGne assemblée en mojes: le «Clumping» 4. SegmentaGon du noyaux: «Pelger Huet» 5. ProjecGons nucléaires ou appendices (caryoschizes) Leuk Res Apr;38(4):

21 R142 Male 83-year-old with: WBC: 1.5 x 10 9 /l Hb: 5.6 g/dl Plt 157 x 10 9 /l Neutrophils: 600 x 10 9 /l Lymphs: 650 x 10 9 /l Monos: 250 x 10 9 /l Bone Marrow: 8% blasts with DysG DysE DysM A1 A A3 A4 A5 A6 1 A7 A8 A9 A10

22 Results R142: 0% granules 100% granules # # # # # # /3

23 R142: Means of ranks with standard deviation for granularity: Mean ranks ,2 2,2 2,7 4,8 5,2 5,7 6,7 8,3 8,8 9,5 devt 0,4 0,8 0,5 1,6 1,0 0,8 0,8 1,5 0,8 0,8 A10 A6 A5 A3 A7 A2 A9 A8 A1 A4 2/3 reducgon granules

24 3rd part: Dysgranulopoiesis: Macropolycytes Macropolycytes: Neutrophils with large size May have double nuclear mass Dysmorphic nucleus Inclusion with dysmorphic neutrophils

25 Normal size

26 15 consecutive neutrophils from a child with an RAEB/AML2 In which you have to identify: Pelger, and Clumping, P8 P4 P3 P2 P1 P9 P7 P5 P6 P10 P15 P13 P11 P12 P14

27

28 4th part: Nuclear ProjecGons DefiniGon: Kosonow and Scupin: (1956) Acta Haematologica 1956, 15, 349. P9 P9 from R#15 Appendage type C

29 Kosonow and Scupin: (1956) Acta Haematologica 1956, 15, 349. Nuclear projecgons have been described using different terms such as: Nuclear projecgons or Sex appendages DrumsGck Nuclear pockets Vesicular appendages Nuclear vesicles The paper from Kosonow classify these chromagn extension in 4 categories: Type A: (sex related) Type B: Type C: Type D:

30 Nuclear ProjecGons Cells with more than 4 NP were not observed in healthy people, and there is a trend To have more NP in the MDS population (see Somers test).

31 Conclusions: Neutrophils: Granularity: 2/3 loss Pelger: 95% concordance Abnormal segmentagon: 91% ChromaGn Clumping: 71% AssociaGon Pelger and Clumping: p=0,002 Macropolycytes: include as dysplas7c Nuclear projecgons: >4NP Eosinophils and Basophils Eosinophils Basophils

32 DysM Micromega Méga mononucléaire MDS/J.E.Goasguen 32

33 DysM Petits noyaux ronds multiples et séparés Plaquettes matures MDS/J.E.Goasguen 33

34 DysM Petits noyaux ronds multiples et séparés cytoplasme granuleux MDS/J.E.Goasguen 34

35 DysM Megacaryoblaste CD41 MDS/J.E.Goasguen 35

36 DysM 5q- MDS/J.E.Goasguen 36

Morfologia normale e patologica

Morfologia normale e patologica Morfologia normale e patologica Gina Zini Centro di Ricerca ReCAMH Dpt. Ematologia Università Cattolica S. Cuore - Roma EMATOLOGIA DI LABORATORIO: percorsi diagnostici e obiettivi clinici. Milano 11-12

More information

DECISION MAKING AND PROBLEM SOLVING ABSTRACT

DECISION MAKING AND PROBLEM SOLVING ABSTRACT DECISION MAKING AND PROBLEM SOLVING Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the

More information

Hematology 101. Blanche P Alter, MD, MPH, FAAP Clinical Genetics Branch Division of Cancer Epidemiology and Genetics Bethesda, MD

Hematology 101. Blanche P Alter, MD, MPH, FAAP Clinical Genetics Branch Division of Cancer Epidemiology and Genetics Bethesda, MD Hematology 101 Blanche P Alter, MD, MPH, FAAP Clinical Genetics Branch Division of Cancer Epidemiology and Genetics Bethesda, MD Hematocrits Plasma White cells Red cells Normal, Hemorrhage, IDA, Leukemia,

More information

Myelodysplastic Syndromes: WHO 2008

Myelodysplastic Syndromes: WHO 2008 Myelodysplastic Syndromes: WHO 2008 Attilio Orazi, M.D., FRCPath. (Engl.) Weill Medical College of Cornell University New York, NY Congresso Nazionale SIE - Società Italiana di Ematologia - MIC Milano

More information

ACCME/Disclosures. History. Hematopathology Specialty Conference Case #4 4/13/2016

ACCME/Disclosures. History. Hematopathology Specialty Conference Case #4 4/13/2016 Hematopathology Specialty Conference Case #4 Sherrie L. Perkins MD, PhD University of Utah ACCME/Disclosures The USCAP requires that anyone in a position to influence or control the content of CME disclose

More information

Hematology Unit Lab 2 Review Material

Hematology Unit Lab 2 Review Material Objectives Hematology Unit Lab 2 Review Material - 2018 Laboratory Instructors: 1. Assist students during lab session Students: 1. Review the introductory material 2. Study the case histories provided

More information

Myelodysplastic Syndromes: Everyday Challenges and Pitfalls

Myelodysplastic Syndromes: Everyday Challenges and Pitfalls Myelodysplastic Syndromes: Everyday Challenges and Pitfalls Kathryn Foucar, MD kfoucar@salud.unm.edu Henry Moon lecture May 2007 Outline Definition Conceptual overview; pathophysiologic mechanisms Incidence,

More information

Participants Identification No. % Evaluation. Mitotic figure Educational Erythrocyte precursor, abnormal 1 0.

Participants Identification No. % Evaluation. Mitotic figure Educational Erythrocyte precursor, abnormal 1 0. Cell Identification Mitotic figure 212 99.5 Educational Erythrocyte precursor, abnormal BMD-02 The arrowed cell is a mitotic figure. It was correctly identified by 99.5% of the participants. A cell containing

More information

Myelodysplastic scoring system with flow cytometry. G Detry B Husson

Myelodysplastic scoring system with flow cytometry. G Detry B Husson Myelodysplastic scoring system with flow cytometry G Detry B Husson Myelodysplastic syndroms Clonal haematopoietic stem cell disease characterized by dysplasia in one or more of the myeloid cell lines

More information

Table 1: biological tests in SMD

Table 1: biological tests in SMD Table 1: biological tests in SMD Tests Mandatory Recommended Under validation Morphology Marrow aspirate Marrow biopsy 1 Iron staining Quantification of dysplasia WHO 2008 Classification Cytogenetics Conventional

More information

Blood Cell Identification Graded

Blood Cell Identification Graded BCP-21 Blood Cell Identification Graded Case History The patient is a 37-year-old female with a history of multiple sickle cell crises. She now presents with avascular necrosis of the left hip. Laboratory

More information

Participants Identification No. % Evaluation. Mitotic figure Educational Erythrocyte precursor, abnormal/

Participants Identification No. % Evaluation. Mitotic figure Educational Erythrocyte precursor, abnormal/ Cell Identification BMD-09 Participants Identification No. % Evaluation Mitotic figure 233 96.7 Educational Erythrocyte precursor, abnormal/ 4 1.7 Educational dysplastic nuclear features Erythrocyte precursor

More information

Ordering Physician CLIENT,CLIENT. Collected REVISED REPORT

Ordering Physician CLIENT,CLIENT. Collected REVISED REPORT HPWET Hematopathology Consultation, MML Embed Client Hematopathology Consult REVISED INAL DIAGNOSIS Interpretation Peripheral blood, bone marrow aspirate and biopsies, bilateral iliac crests: 1. Normocellular

More information

EDUCATIONAL COMMENTARY BLOOD CELL IDENTIFICATION

EDUCATIONAL COMMENTARY BLOOD CELL IDENTIFICATION EDUCATIONAL COMMENTARY BLOOD CELL IDENTIFICATION Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE credits click

More information

Lymphoma Tumor Board Quiz! Laboratory Hematology: Basic Cell Morphology

Lymphoma Tumor Board Quiz! Laboratory Hematology: Basic Cell Morphology Lymphoma Tumor Board Quiz! Laboratory Hematology: Basic Cell Morphology CABOT RINGS Cabot rings in a patient with hemolytic anemia. Cabot ring (red arrow) and Howell-Jolly body (blue arrow). Observed in

More information

MYELODYSPLASTIC SYNDROMES

MYELODYSPLASTIC SYNDROMES MYELODYSPLASTIC SYNDROMES Babak Tamizi Far MD. Assistant professor of internal medicine Al-zahra university hospital, Isfahan university of medical sciences Key Features ESSENTIALS OF DIAGNOSIS Cytopenias

More information

Hematopathology Lab. Third year medical students

Hematopathology Lab. Third year medical students Hematopathology Lab Third year medical students Objectives Identify the lesion Know the specific name of the lesion Know associated disease Know relevant pathologic background Spherocytes: appear small,

More information

VETERINARY HEMATOLOGY ATLAS OF COMMON DOMESTIC AND NON-DOMESTIC SPECIES COPYRIGHTED MATERIAL SECOND EDITION

VETERINARY HEMATOLOGY ATLAS OF COMMON DOMESTIC AND NON-DOMESTIC SPECIES COPYRIGHTED MATERIAL SECOND EDITION VETERINARY HEMATOLOGY ATLAS OF COMMON DOMESTIC AND NON-DOMESTIC SPECIES SECOND EDITION COPYRIGHTED MATERIAL CHAPTER ONE HEMATOPOIESIS GENERAL FEATURES All blood cells have a finite life span, but in normal

More information

What is MDS? Epidemiology, Diagnosis, Classification & Risk Stratification

What is MDS? Epidemiology, Diagnosis, Classification & Risk Stratification What is MDS? Epidemiology, Diagnosis, Classification & Risk Stratification Rami Komrokji, MD Clinical Director Malignant Hematology Moffitt Cancer Center Normal Blood and Bone Marrow What is MDS Myelodysplastic

More information

Case Presentation. Attilio Orazi, MD

Case Presentation. Attilio Orazi, MD Case Presentation Attilio Orazi, MD Weill Cornell Medical College/ NYP Hospital Department of Pathology and Laboratory Medicine New York, NY United States History 60 year old man presented with anemia

More information

EDUCATIONAL COMMENTARY DISTINGUISHING MORPHOLOGIC LOOK-ALIKES

EDUCATIONAL COMMENTARY DISTINGUISHING MORPHOLOGIC LOOK-ALIKES EDUCATIONAL COMMENTARY DISTINGUISHING MORPHOLOGIC LOOK-ALIKES Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE

More information

MORPHOLOGY OF BONE MARROW ASPIRATES. Dr.Prasanna N Kumar Head Department of Pathology, Oman Medical College, Oman

MORPHOLOGY OF BONE MARROW ASPIRATES. Dr.Prasanna N Kumar Head Department of Pathology, Oman Medical College, Oman MORPHOLOGY OF BONE MARROW ASPIRATES Dr.Prasanna N Kumar Head Department of Pathology, Oman Medical College, Oman BONE MARROW ASPIRATION Sites Sternum Anterior or posterior iliac spines Aspiration from

More information

Usefulness of NEUT-X determination in routine diagnostic procedures: application to myelodysplastic syndromes. F. Cymbalista.

Usefulness of NEUT-X determination in routine diagnostic procedures: application to myelodysplastic syndromes. F. Cymbalista. Usefulness of NEUT-X determination in routine diagnostic procedures: application to myelodysplastic syndromes F. Cymbalista Myelodysplastic syndromes (MDS) are common malignant disorders with a poor prognosis.

More information

Juvenile Myelomonocytic Leukemia (JMML)

Juvenile Myelomonocytic Leukemia (JMML) Juvenile Myelomonocytic Leukemia (JMML) JMML: Definition Monoclonal hematopoietic disorder of childhood characterized by proliferation of the granulocytic and monocytic lineages Erythroid and megakaryocytic

More information

Evaluation of Bone Marrow Biopsies and Aspirates ANNA PORWIT DEPARTMENT OF PATHOLOGY, LUND UNIVERSITY

Evaluation of Bone Marrow Biopsies and Aspirates ANNA PORWIT DEPARTMENT OF PATHOLOGY, LUND UNIVERSITY Evaluation of Bone Marrow Biopsies and Aspirates ANNA PORWIT DEPARTMENT OF PATHOLOGY, LUND UNIVERSITY DISCLOSURES NONE Learning objectives To review the rules of BMA evaluation To review the main issues

More information

MYELODYSPLASTIC SYNDROMES: A diagnosis often missed

MYELODYSPLASTIC SYNDROMES: A diagnosis often missed MYELODYSPLASTIC SYNDROMES: A diagnosis often missed D R. EMMA W YPKEMA C O N S U LTA N T H A E M AT O L O G I S T L A N C E T L A B O R AT O R I E S THE MYELODYSPLASTIC SYNDROMES DEFINITION The Myelodysplastic

More information

Myelodysplastic syndromes and the new WHO 2016 classification

Myelodysplastic syndromes and the new WHO 2016 classification Myelodysplastic syndromes and the new WHO 2016 classification 32nd General Annual Meeting of the Belgian Hematology Society 10-11 February 2017 Gregor Verhoef, Departement of Hematology, University Hospital

More information

By Dr. Mohamed Saad Daoud

By Dr. Mohamed Saad Daoud By Dr. Mohamed Saad Daoud Part I Introduction Types of White Blood Cells Genesis of the White Blood Cells Life Span of the White Blood Cells Dr. Mohamed Saad Daoud 2 Leucocytes Introduction: Infectious

More information

Notes for the 2 nd histology lab

Notes for the 2 nd histology lab Notes for the 2 nd histology lab Note : Please refer to the slides and see the morphological characteristics of each cell, as the practical exam will be in the form of figures. SLIDE #2 Erythropoiesis

More information

2 nd step do Bone Marrow Study If possible both the aspiration and

2 nd step do Bone Marrow Study If possible both the aspiration and Blood Malignancies-I Prof. Herman Hariman,SpPK a (KH). Ph.D.(U.K) Prof. Dr. Adikoesoema Aman, SpPK (KH) Dept. Clinpath, FK-USU First do the Full Blood Count Hb, WBCS, Platelets Morphology!! Such as blasts,

More information

Aplastic Anemia & MDS International Foundation Talk. Definition. Introduction 4/20/2012. April 2012 H. Phillip Koeffler, M.D.

Aplastic Anemia & MDS International Foundation Talk. Definition. Introduction 4/20/2012. April 2012 H. Phillip Koeffler, M.D. Aplastic Anemia & MDS International Foundation Talk April 2012 H. Phillip Koeffler, M.D. Definition Myelo Greek prefix; marrow Dysplasia abnormal morphology Can affect: RBCs WBCs Plts Introduction 1949:

More information

Myelodysplastic Syndromes: Hematopathology. Analysis of SHIP1 as a potential biomarker of Disease Progression

Myelodysplastic Syndromes: Hematopathology. Analysis of SHIP1 as a potential biomarker of Disease Progression Myelodysplastic Syndromes: Hematopathology. Analysis of SHIP1 as a potential biomarker of Disease Progression Carlos E. Bueso-Ramos, M.D., Ph.D Department of Hematopathology The University of Texas M.

More information

ADx Bone Marrow Report. Patient Information Referring Physician Specimen Information

ADx Bone Marrow Report. Patient Information Referring Physician Specimen Information ADx Bone Marrow Report Patient Information Referring Physician Specimen Information Patient Name: Specimen: Bone Marrow Site: Left iliac Physician: Accession #: ID#: Reported: 08/19/2014 - CHRONIC MYELOGENOUS

More information

Cell sorting: A bridge between morphology and flow cytometry. Pr François Mullier, Pr Bernard Chatelain July 19th, 2013

Cell sorting: A bridge between morphology and flow cytometry. Pr François Mullier, Pr Bernard Chatelain July 19th, 2013 Cell sorting: A bridge between morphology and flow cytometry Pr François Mullier, Pr Bernard Chatelain July 19th, 2013 1 CELL SORTING: PRINCIPLES D.Davies CELL SORTING: PRINCIPLES Aims Efficiency Purity

More information

SH A CASE OF PERSISTANT NEUTROPHILIA: BCR-ABL

SH A CASE OF PERSISTANT NEUTROPHILIA: BCR-ABL SH2017-0124 A CASE OF PERSISTANT NEUTROPHILIA: BCR-ABL NEGATIVE John R Goodlad 1, Pedro Martin-Cabrera 2, Catherine Cargo 2 1. Department of Pathology, NHS Greater Glasgow & Clyde, QEUH, Glasgow 2. Haematological

More information

RAEB-2 2 Transforming to Acute Erythroleukemia Case # 165

RAEB-2 2 Transforming to Acute Erythroleukemia Case # 165 RAEB-2 2 Transforming to Acute Erythroleukemia Case # 165 Sebastian J. Sasu, M.D. UCLA Medical Center, Hematopathology Los Angeles, CA and Saint John s s Health Center Santa Monica, CA Clinical History

More information

Bone Marrow. Procedures Blood Film Aspirate, Cell Block Trephine Biopsy, Touch Imprint

Bone Marrow. Procedures Blood Film Aspirate, Cell Block Trephine Biopsy, Touch Imprint Bone Marrow Protocol applies to acute leukemias, myelodysplastic syndromes, myeloproliferative disorders, chronic lymphoproliferative disorders, malignant lymphomas, plasma cell dyscrasias, histiocytic

More information

HENATOLYMPHOID SYSTEM THIRD YEAR MEDICAL STUDENTS- UNIVERSITY OF JORDAN AHMAD T. MANSOUR, MD. Part 4 MYELOID NEOPLASMS

HENATOLYMPHOID SYSTEM THIRD YEAR MEDICAL STUDENTS- UNIVERSITY OF JORDAN AHMAD T. MANSOUR, MD. Part 4 MYELOID NEOPLASMS HENATOLYMPHOID SYSTEM THIRD YEAR MEDICAL STUDENTS- UNIVERSITY OF JORDAN AHMAD T. MANSOUR, MD Part 4 MYELOID NEOPLASMS Introduction: o Myeloid neoplasms are divided into three major categories: o Acute

More information

Myelodysplastic syndromes

Myelodysplastic syndromes Myelodysplastic syndromes Robert P Hasserjian Massachusetts General Hospital, Boston, MA Disclosure of Relevant Financial Relationships Dr. Hasserjian declares he has no conflict(s) of interest to disclose.

More information

Changes to the 2016 WHO Classification for the Diagnosis of MDS

Changes to the 2016 WHO Classification for the Diagnosis of MDS Changes to the 2016 WHO Classification for the Diagnosis of MDS Welcome to Managing MDS. I am Dr. Ulrich Germing, and today, I will provide highlights from the 14th International Symposium on MDS in Valencia,

More information

THE HISTOLOGICAL OVERVIEW TO MYELODYSPLASTIC SYNDROMES: EVALUATION OF BONE MARROW SMEARS AND BIOPSIES

THE HISTOLOGICAL OVERVIEW TO MYELODYSPLASTIC SYNDROMES: EVALUATION OF BONE MARROW SMEARS AND BIOPSIES Journal of Disease and Global Health 6(3): 102-106, 2016 ISSN: 2454-1842 International Knowledge Press www.ikpress.org THE HISTOLOGICAL OVERVIEW TO MYELODYSPLASTIC SYNDROMES: EVALUATION OF BONE MARROW

More information

ORIGINAL ARTICLE. E Verburgh 1, R Achten 2, VJ Louw 1, C Brusselmans 1, M Delforge 1, M Boogaerts 1, A Hagemeijer 3, P Vandenberghe 3 and G Verhoef 1

ORIGINAL ARTICLE. E Verburgh 1, R Achten 2, VJ Louw 1, C Brusselmans 1, M Delforge 1, M Boogaerts 1, A Hagemeijer 3, P Vandenberghe 3 and G Verhoef 1 (2007) 21, 668 677 & 2007 Nature Publishing Group All rights reserved 0887-6924/07 $30.00 www.nature.com/leu ORIGINAL ARTICLE A new disease categorization of low-grade myelodysplastic syndromes based on

More information

Primary myelofibrosis

Primary myelofibrosis - It s a bone marrow fibrosis Primary myelofibrosis - It's type of myeloproliferative disease i.e. neoplastic proliferation of mature cell of myloid linage. - Its similar to chronic myloid leukemia (CML).

More information

HEMATOLOGIC MORPHOLOGY- AECOM HEMATOLOGY COURSE

HEMATOLOGIC MORPHOLOGY- AECOM HEMATOLOGY COURSE Log Out Help current login :lcytryn@montefiore.org HEMATOLOGIC MORPHOLOGY- AECOM HEMATOLOGY COURSE Lawrence Cytryn, M.D. - Course Director 1998 Edward Burns, M.D. Images used by permission within AECOM

More information

Formation of Blood Cells

Formation of Blood Cells Hematopoiesis Lecture Objectives Name organs responsible for hematopoiesis in the fetus. List the developmental stages of hematopoiesis both prenatally and postnatally. Outline the major steps of post

More information

About Myelodysplastic Syndromes

About Myelodysplastic Syndromes About Myelodysplastic Syndromes Overview and Types If you have been diagnosed with a myelodysplastic syndrome or are worried about it, you likely have a lot of questions. Learning some basics is a good

More information

Myelodysplastic Syndrome Case 158

Myelodysplastic Syndrome Case 158 Myelodysplastic Syndrome Case 158 Dong Chen MD PhD Division of Hematopathology Mayo Clinic Clinical History 86 year old man Persistent borderline anemia and thrombocytopenia. His past medical history was

More information

Flow Cytomety Immunophenotyping For Myelodysplastic Syndromes. Sa A.Wang, MD Dept. of Hematopathology UT MD Anderson Cancer Center Houston, TX

Flow Cytomety Immunophenotyping For Myelodysplastic Syndromes. Sa A.Wang, MD Dept. of Hematopathology UT MD Anderson Cancer Center Houston, TX Flow Cytomety Immunophenotyping For Myelodysplastic Syndromes Sa A.Wang, MD Dept. of Hematopathology UT MD Anderson Cancer Center Houston, TX Myelodysplastic Syndromes Definition: A group of heterogeneous

More information

HISTOLOGY VIRTUAL LABORATORY BLOOD AND LYMPHATICS SYSTEM

HISTOLOGY VIRTUAL LABORATORY BLOOD AND LYMPHATICS SYSTEM HISTOLOGY VIRTUAL LABORATORY BLOOD AND LYMPHATICS SYSTEM Login: http://histopath.westernu.edu Histology Atlas AND Virtual Histology links. I. HEMATOLOGY - PERIPHERAL BLOOD Purpose: To be able to identify

More information

A prospective, multicenter European Registry for newly diagnosed patients with Myelodysplastic Syndromes of IPSS low and intermediate-1 subtypes.

A prospective, multicenter European Registry for newly diagnosed patients with Myelodysplastic Syndromes of IPSS low and intermediate-1 subtypes. Protocol Synopsis Study Title A prospective, multicenter European Registry for newly diagnosed patients with Myelodysplastic Syndromes of IPSS low and intermediate-1 subtypes. Short Title European MDS

More information

EDUCATIONAL COMMENTARY MORPHOLOGIC ABNORMALITIES IN LEUKOCYTES

EDUCATIONAL COMMENTARY MORPHOLOGIC ABNORMALITIES IN LEUKOCYTES EDUCATIONAL COMMENTARY MORPHOLOGIC ABNORMALITIES IN LEUKOCYTES Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE

More information

Blood DLC, Retic count, PCV, Hb and ESR. Dr. Tamara Alqudah

Blood DLC, Retic count, PCV, Hb and ESR. Dr. Tamara Alqudah Blood DLC, Retic count, PCV, Hb and ESR Dr. Tamara Alqudah Differential Leukocyte Count (DLC) There are 5 main types of WBCs: 1. Neutrophils: 40-80% 2. Eosinophils: 1-6 % 3. Basophils: < 1-2% 4. Lymphocytes:

More information

Leukaemia Section Review

Leukaemia Section Review Atlas of Genetics and Cytogenetics in Oncology and Haematology OPEN ACCESS JOURNAL AT INIST-CNRS Leukaemia Section Review Classification of myelodysplasic syndromes Georges Flandrin Laboratoire d'hématologie,

More information

MDS-004 Study: REVLIMID (lenalidomide) versus Placebo in Myelodysplastic Syndromes with Deletion (5q) Abnormality

MDS-004 Study: REVLIMID (lenalidomide) versus Placebo in Myelodysplastic Syndromes with Deletion (5q) Abnormality MDS-4 Study: REVLIMID (lenalidomide) versus Placebo in Myelodysplastic Syndromes with Deletion (5q) Abnormality TABLE OF CONTENTS Section 1. Executive Summary Section 2. Background Section

More information

Overview of guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload

Overview of guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload Int J Hematol (2008) 88:24 29 DOI 10.1007/s12185-008-0118-z PROGRESS IN HEMATOLOGY Transfusional iron overload and iron chelation therapy Overview of guidelines on iron chelation therapy in patients with

More information

EDUCATIONAL COMMENTARY DIFFERENTIATING IMMATURE PERIPHERAL BLOOD CELLS

EDUCATIONAL COMMENTARY DIFFERENTIATING IMMATURE PERIPHERAL BLOOD CELLS Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE credits click on Continuing Education on the left side of the

More information

New system for assessing the prognosis of refractory anemia patients

New system for assessing the prognosis of refractory anemia patients Leukemia (1999) 13, 1727 1734 1999 Stockton Press All rights reserved 0887-6924/99 $15.00 http://www.stockton-press.co.uk/leu New system for assessing the prognosis of refractory anemia patients A Matsuda

More information

APPROACHING TO PANCYTOPENIA

APPROACHING TO PANCYTOPENIA APPROACHING TO PANCYTOPENIA P A T C H A R E E K O M V I L A I S A K, M. D. A S S I S T A N T P R O F E S S O R D I V I S I O N O F P E D I A T R I C H E M A T O L O G Y O N C O L O G Y, D E P A R T M E

More information

Outline. Case Study 5/17/2010. Treating Lower-Risk Myelodysplastic Syndrome (MDS) Tapan M. Kadia, MD Department of Leukemia MD Anderson Cancer Center

Outline. Case Study 5/17/2010. Treating Lower-Risk Myelodysplastic Syndrome (MDS) Tapan M. Kadia, MD Department of Leukemia MD Anderson Cancer Center Treating Lower-Risk Myelodysplastic Syndrome (MDS) Tapan M. Kadia, MD Department of Leukemia MD Anderson Cancer Center Outline Case Study What is lower-risk MDS? Classification systems Prognosis Treatment

More information

Idiopathic Macrocytosis in Smokers

Idiopathic Macrocytosis in Smokers ORIGINAL ARTICLE Ningen Dock 27 : 689-696, 2012 Idiopathic Macrocytosis in Smokers Masuhiro Takahashi 1), Akie Yamahira 1), Takayoshi Uchiyama 1), Minami Iwabuchi 1), Naoya Sato 1), Jun Takizawa 2), Hirohito

More information

Better Prognosis for Patients With Del(7q) Than for Patients With Monosomy 7 in Myelodysplastic Syndrome

Better Prognosis for Patients With Del(7q) Than for Patients With Monosomy 7 in Myelodysplastic Syndrome Better Prognosis for Patients With Del(7q) Than for Patients With Monosomy 7 in Myelodysplastic Syndrome Iris Cordoba, MD 1 ; José R. González-Porras, MD 1 ; Benet Nomdedeu, MD 2 ; Elisa Luño, MD 3 ; Raquel

More information

Blood Cell Identification Graded

Blood Cell Identification Graded Blood Cell Identification Graded Case History The patient was a five-day-old girl with an elevated unconjugated bilirubin and a weakly positive direct antiglobulin test (DAT). Her CBC showed: WBC = 11.0

More information

Megakaryocyte or Precursor, Normal

Megakaryocyte or Precursor, Normal Precursor, Normal SYNONYMS none VITAL STATISTICS size...20-160 µm in diameter N:C ratio...varible, depending on maturation of cell; early forms have a high N:C rato which decreases as cell matures and

More information

COMPANY OR UNIVERSITY

COMPANY OR UNIVERSITY CONTRIBUTOR NAME Daniel Heinrich, DVM CONTRIBUTOR EMAIL dheinric@umn.edu COAUTHORS Jed Overmann, DVM, DACVP; Davis Seelig DVM, PhD, DACVP & Matthew Sturos, DVM COMPANY OR UNIVERSITY University of Minnesota

More information

MS.4/ 1.Nov/2015. Acute Leukemia: AML. Abdallah Abbadi

MS.4/ 1.Nov/2015. Acute Leukemia: AML. Abdallah Abbadi MS.4/ 1.Nov/2015. Acute Leukemia: AML Abdallah Abbadi Case 9: Acute Leukemia 29 yr old lady complains of fever and painful gums for 1 week. She developed easy bruising and hemorrhagic spots on her trunk

More information

Acta Medica Okayama. Studies on diagnosis of leukemia by tissue culture. Kiyoshi Hiraki APRIL Volume 12, Issue Article 8

Acta Medica Okayama. Studies on diagnosis of leukemia by tissue culture. Kiyoshi Hiraki APRIL Volume 12, Issue Article 8 Acta Medica Okayama Volume 12, Issue 1 1958 Article 8 APRIL 1958 Studies on diagnosis of leukemia by tissue culture Kiyoshi Hiraki Okayama University, Copyright c 1999 OKAYAMA UNIVERSITY MEDICAL SCHOOL.

More information

Proper Slide Preparation

Proper Slide Preparation Hematology Essentials: A Foundation for WBC Review Using Case Studies Christine Hinz, MS, MLS(ASCP) CM Proper Slide Preparation smooth, homogenous film 1/2 to 3/4 the slide length straight feather edge

More information

Classification of Hematologic Malignancies. Patricia Aoun MD MPH

Classification of Hematologic Malignancies. Patricia Aoun MD MPH Classification of Hematologic Malignancies Patricia Aoun MD MPH Objectives Know the basic principles of the current classification system for hematopoietic and lymphoid malignancies Understand the differences

More information

Network Guidance Document. Oncological treatment of Haematology. Myelodysplastic Syndromes (MDS) Final. Status: November 2012.

Network Guidance Document. Oncological treatment of Haematology. Myelodysplastic Syndromes (MDS) Final. Status: November 2012. Network Guidance Document Oncological treatment of Haematology Myelodysplastic Syndromes (MDS) Status: Final Expiry Date: November 2012 Version Number: 1 Publication Date: November 2010 Page 1 of 14T:\DOG

More information

Leukocytosis - Some Learning Points

Leukocytosis - Some Learning Points Leukocytosis - Some Learning Points Koh Liang Piu Department of Hematology-Oncology National University Cancer Institute National University Health System Objectives of this talk: 1. To provide some useful

More information

Beyond the CBC Report: Extended Laboratory Testing in the Evaluation for Hematologic Neoplasia Disclosure

Beyond the CBC Report: Extended Laboratory Testing in the Evaluation for Hematologic Neoplasia Disclosure Beyond the CBC Report: Extended Laboratory Testing in the Evaluation for Hematologic Neoplasia Disclosure I am receiving an honorarium from Sysmex for today s presentation. 1 Determining the Etiology for

More information

short report Summary Keywords: blood cell morphology, myelodysplasia, haematological malignancies

short report Summary Keywords: blood cell morphology, myelodysplasia, haematological malignancies short report A European consensus report on blood cell identification: terminology utilized and morphological diagnosis concordance among 28 experts from 17 countries within the European LeukemiaNet network

More information

EDUCATIONAL COMMENTARY MORPHOLOGIC CHANGES IN PERIPHERAL BLOOD CELLS

EDUCATIONAL COMMENTARY MORPHOLOGIC CHANGES IN PERIPHERAL BLOOD CELLS EDUCATIONAL COMMENTARY MORPHOLOGIC CHANGES IN PERIPHERAL BLOOD CELLS Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE

More information

SEED HAEMATOLOGY. The blast cell a diagnostic heavyweight SYSMEX EDUCATIONAL ENHANCEMENT AND DEVELOPMENT NOVEMBER 2016

SEED HAEMATOLOGY. The blast cell a diagnostic heavyweight SYSMEX EDUCATIONAL ENHANCEMENT AND DEVELOPMENT NOVEMBER 2016 SYSMEX EDUCATIONAL ENHANCEMENT AND DEVELOPMENT NOVEMBER 2016 SEED HAEMATOLOGY The blast cell a diagnostic heavyweight Causes and cytological manifestations Blast cells are described as precursor cells

More information

Border between aplastic anemia and myelodysplastic syndrome

Border between aplastic anemia and myelodysplastic syndrome Int J Hematol (2013) 97:558 563 DOI 10.1007/s12185-013-1324-x PROGRESS IN HEMATOLOGY Advances in the management of acquired aplastic anemia (AA) Border between aplastic anemia and myelodysplastic syndrome

More information

Impact of Comorbidity on Quality of Life and Clinical Outcomes in MDS

Impact of Comorbidity on Quality of Life and Clinical Outcomes in MDS Current Therapeutic and Biologic Advances in MDS A Symposium of The MDS Foundation ASH 2014 Impact of Comorbidity on Quality of Life and Clinical Outcomes in MDS Peter Valent Medical University of Vienna

More information

Myelodysplastic syndromes in adults aged less than 50 years: Incidence and clinicopathological data

Myelodysplastic syndromes in adults aged less than 50 years: Incidence and clinicopathological data JBUON 2014; 19(4): 999-1005 ISSN: 1107-0625, online ISSN: 2241-6293 www.jbuon.com E-mail: editorial_office@jbuon.com ORIGINAL ARTICLE Myelodysplastic syndromes in adults aged less than 50 years: Incidence

More information

Myelodysplastic syndromes: revised WHO classification and distinction from non-neoplastic conditions

Myelodysplastic syndromes: revised WHO classification and distinction from non-neoplastic conditions Myelodysplastic syndromes: revised WHO classification and distinction from non-neoplastic conditions Robert P Hasserjian, MD Associate Professor Massachusetts General Hospital and Harvard Medical School

More information

Blood Cell Identification Graded

Blood Cell Identification Graded Blood Cell Identification Graded Case History A 51-year-old female presented with dyspnea on exertion. Laboratory results were as follows: WBC=5.5 X 10 9 /L; Hgb=4.2 g/dl; Hct=13.9%; MCV=78.7fL; RDW=30;

More information

MYELOPROLIFERATIVE DISEASE. Dr Mere Kende MBBS (UPNG), MMED (Path),MAACB, MACTM, MACRRM (Aus) Lecturer-SMHS UPNG

MYELOPROLIFERATIVE DISEASE. Dr Mere Kende MBBS (UPNG), MMED (Path),MAACB, MACTM, MACRRM (Aus) Lecturer-SMHS UPNG MYELOPROLIFERATIVE DISEASE Dr Mere Kende MBBS (UPNG), MMED (Path),MAACB, MACTM, MACRRM (Aus) Lecturer-SMHS UPNG Myeloproliferative Diseases Essential to diagnosis Acquired clonal abnormalities of the hematopoietic

More information

2007 Workshop of Society for Hematopathology & European Association for Hematopathology Indianapolis, IN, USA Case # 228

2007 Workshop of Society for Hematopathology & European Association for Hematopathology Indianapolis, IN, USA Case # 228 2007 Workshop of Society for Hematopathology & European Association for Hematopathology Indianapolis, IN, USA Case # 228 Vishnu V. B Reddy, MD University of Alabama at Birmingham Birmingham, AL USA 11/03/07

More information

EHE1-16 Participants Identification No. % Evaluation

EHE1-16 Participants Identification No. % Evaluation Cell Identification EHE1-16 Participants Identification No. % Evaluation Blast cell 154 90.1 Educational Lymphocyte 4 2.3 Educational Lymphocyte, reactive 1 0.6 Educational Lymphoma cell (malignant) 1

More information

CASE 106. Pancytopenia in the setting of marrow hypoplasia, a PNH clone, and a DNMT3A mutation

CASE 106. Pancytopenia in the setting of marrow hypoplasia, a PNH clone, and a DNMT3A mutation CASE 106 Pancytopenia in the setting of marrow hypoplasia, a PNH clone, and a DNMT3A mutation Gabriel C. Caponetti, MD University of Pennsylvania, US Clinical history 69, F peripheral neuropathy, refractory

More information

4. TEXTBOOK: ABUL K. ABBAS. ANDREW H. LICHTMAN. CELLULAR AND MOLECULAR IMMUNOLOGY. 5 TH EDITION. Chapter 2. pg

4. TEXTBOOK: ABUL K. ABBAS. ANDREW H. LICHTMAN. CELLULAR AND MOLECULAR IMMUNOLOGY. 5 TH EDITION. Chapter 2. pg LECTURE: 03 Title: CELLS INVOLVED IN THE IMMUNE RESPONSE LEARNING OBJECTIVES: The student should be able to: Identify the organs where the process of the blood formation occurs. Identify the main cell

More information

NEW YORK STATE CYTOHEMATOLOGY PROFICIENCY TEST PROGRAM Glass Slide - November 2016

NEW YORK STATE CYTOHEMATOLOGY PROFICIENCY TEST PROGRAM Glass Slide - November 2016 NEW YORK STATE CYTOHEMATOLOGY PROFICIENCY TEST PROGRAM Glass Slide - November 2016 Results from this proficiency test event are available at: http://www.wadsworth.org/regulatory/clep/pt/summaries SLIDE

More information

Myelodysplastic Neoplasms. Myelodysplastic Neoplasms Con t

Myelodysplastic Neoplasms. Myelodysplastic Neoplasms Con t Myelodysplastic Neoplasms Found primarily in patients older than 50 years Characterized by indolence, peripheral p cytopenias, hypercellular marrow, less than 20% blasts, and varying amounts and degrees

More information

Blood: Functions. Liquid connective tissue 3 general functions 1. Transportation. 2. Regulation. 3. Protection

Blood: Functions. Liquid connective tissue 3 general functions 1. Transportation. 2. Regulation. 3. Protection Blood Elements Lecture Objectives List blood components. Classify formed elements of blood. Discuss the scientific basis of the above classification. Describe the basic structure of erythrocytes and criteria

More information

Pathology. #11 Acute Leukemias. Farah Banyhany. Dr. Sohaib Al- Khatib 23/2/16

Pathology. #11 Acute Leukemias. Farah Banyhany. Dr. Sohaib Al- Khatib 23/2/16 35 Pathology #11 Acute Leukemias Farah Banyhany Dr. Sohaib Al- Khatib 23/2/16 1 Salam First of all, this tafreegh is NOT as long as you may think. If you just focus while studying this, everything will

More information

Done By : WESSEN ADNAN BUTHAINAH AL-MASAEED

Done By : WESSEN ADNAN BUTHAINAH AL-MASAEED Done By : WESSEN ADNAN BUTHAINAH AL-MASAEED Acute Myeloid Leukemia Firstly we ll start with this introduction then enter the title of the lecture, so be ready and let s begin by the name of Allah : We

More information

Hemopoiesis and Blood

Hemopoiesis and Blood Hemopoiesis and Blood Blood Cells o o o Erythrocytes Leukocytes Thrombocytes Function o Transport nutrients and wastes throughout the bloodstream, fight foreign antigens and blood coagulation. Location

More information

Allogeneic Hematopoietic Stem-Cell Transplantation for Myelodysplastic Syndromes and Myeloproliferative Neoplasms. Policy Specific Section:

Allogeneic Hematopoietic Stem-Cell Transplantation for Myelodysplastic Syndromes and Myeloproliferative Neoplasms. Policy Specific Section: Medical Policy Allogeneic Hematopoietic Stem-Cell Transplantation for Myelodysplastic Syndromes and Myeloproliferative Type: Medical Necessity and Investigational / Experimental Policy Specific Section:

More information

Case Presentation No. 075

Case Presentation No. 075 Case Presentation No. 075 Session 4. Myelodysplastic Syndrome Cristina Montalvo, MD Baylor College of Medicine Houston, Texas 2007 Workshop of Society for Hematopathology and European Association for Haematopathology

More information

LENALIDOMIDA EN EL SMD 5Q-

LENALIDOMIDA EN EL SMD 5Q- LENALIDOMIDA EN EL SMD 5Q- EXPERIENCIA ESPAÑOLA 37 Diada Internacional 7 de Junio de 2013 M. Díez Campelo Hematología HOSPITAL UNIVERSITARIO 15-30% MDS Introduction Sole anomaly or in addition to 1 cytogenetics

More information

Letter to the Editor. Effect of edta-anticoagulated whole blood storage on cell morphology examination. A need for standardization

Letter to the Editor. Effect of edta-anticoagulated whole blood storage on cell morphology examination. A need for standardization International Journal of Laboratory Hematology LETTER TO THE EDITOR The Official journal of the International Society for Laboratory Hematology INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY Letter to

More information

Blood Cell Identification Graded

Blood Cell Identification Graded Blood Cell Identification Graded Case History An 11-year-old girl presented to the emergency room with wheezing and was diagnosed as having asthma. Her CBC showed WBC = 12.5 x 10 9 /L; Hgb = 12.4g/dL;

More information

Myelodysplastic Syndromes Myeloproliferative Disorders

Myelodysplastic Syndromes Myeloproliferative Disorders Myelodysplastic Syndromes Myeloproliferative Disorders Myelodysplastic Syndromes characterized by maturation defects that are associated with ineffective hematopoiesis and a high risk of transformation

More information

Chronic Myelomonocytic Leukemia with molecular abnormalities SH

Chronic Myelomonocytic Leukemia with molecular abnormalities SH Chronic Myelomonocytic Leukemia with molecular abnormalities SH2017-0351 Madhu P. Menon MD,PhD, Juan Gomez MD, Kedar V. Inamdar MD,PhD and Kristin Karner MD Madhu P Menon, MD, PhD Henry Ford Hospital Patient

More information

Flow Cytometry. What is flow cytometry?

Flow Cytometry. What is flow cytometry? Flow Cytometry Flow Cytometry What is flow cytometry? Flow cytometry is a popular laser-based technology to analyze the characteristics of cells or particles. It is predominantly used to measure fluorescence

More information

MDS 101. What is bone marrow? Myelodysplastic Syndrome: Let s build a definition. Dysplastic? Syndrome? 5/22/2014. What does bone marrow do?

MDS 101. What is bone marrow? Myelodysplastic Syndrome: Let s build a definition. Dysplastic? Syndrome? 5/22/2014. What does bone marrow do? 101 May 17, 2014 Myelodysplastic Syndrome: Let s build a definition Myelo bone marrow Gail J. Roboz, M.D. Director, Leukemia Program Associate Professor of Medicine What is bone marrow? What does bone

More information

APPROACH TO MYELODYSPLASTIC SYNDROMES IN THE ERA OF PRECISION MEDICINE

APPROACH TO MYELODYSPLASTIC SYNDROMES IN THE ERA OF PRECISION MEDICINE APPROACH TO MYELODYSPLASTIC SYNDROMES IN THE ERA OF PRECISION MEDICINE Rashmi Kanagal-Shamanna, MD Assistant Professor Hematopathology & Molecular Diagnostics Department of Hematopathology The University

More information